Akums Drugs and Pharmaceuticals Limited IPO

Akums Drugs and Pharmaceuticals Limited IPO

Akums Drugs and Pharmaceuticals Limited is a prominent pharmaceutical manufacturing company in India. Here’s an overview of the company:

Overview

  • Founded: Akums Drugs and Pharmaceuticals Limited was established in 2004.
  • Location: The company is based in Haridwar, Uttarakhand, India.
  • Industry: Pharmaceuticals and Nutraceuticals.

Services and Products

Akums is known for manufacturing a wide range of pharmaceutical formulations. They offer services in various categories, including:

  • Pharmaceutical Manufacturing: Akums manufactures a broad spectrum of pharmaceutical products, including tablets, capsules, injections, syrups, ointments, and more.
  • Nutraceuticals: The company also produces nutraceutical products, which are food products that provide medical or health benefits, including the prevention and treatment of disease.
  • Ayurvedic and Herbal Products: Akums has a strong presence in the Ayurvedic and herbal product market, offering a range of traditional medicine products.
  • Cosmeceuticals: They also produce cosmeceuticals, which are cosmetic products with bioactive ingredients purported to have medical benefits.

Manufacturing Facilities

Akums boasts state-of-the-art manufacturing facilities that comply with various national and international standards, including WHO-GMP (World Health Organization – Good Manufacturing Practices). They have multiple plants across India, equipped with advanced machinery and technology to ensure high-quality production.

Quality and Compliance

Quality assurance is a critical focus for Akums. The company follows stringent quality control measures and has received various certifications for its quality management systems, including ISO certifications.

Clientele and Partnerships

Akums serves a diverse clientele, including multinational pharmaceutical companies, domestic firms, and other businesses. They are known for contract manufacturing and have established partnerships with numerous companies for the production of branded and generic formulations.

Research and Development

The company invests in research and development to innovate and improve its product offerings. This includes the development of new formulations, processes, and technologies to enhance product quality and efficiency.

Akums Drugs and Pharmaceuticals Limited IPO Tentative Timetable

ParticularDate
IPO Open Date30 July 2024
IPO Close Date01 Aug 2024
Allotment Date02 Aug 2024
IPO Listing Date06 Aug 2024

Akums Drugs and Pharmaceuticals Limited IPO Details

Issue TypeBook Built Issue IPO
Face ValueRs. 2 Per Equity Share
IPO PriceRs. 646 to Rs. 679 Per Equity Share
Market Lot22 Share
ISIN Code
Listing AtNSE, & BSE
Issue SizeApprox. Rs. 1857 Crore.

Akums Drugs and Pharmaceuticals Limited IPO Lot Size

ApplicationLotsSharesAmount
Minimum122Rs. 14938
Maximum13286Rs. 194194
Small HNI (Minimum)14308Rs. 209132
Big HNI (Minimum)671474Rs. 1000846

Akums Drugs and Pharmaceuticals Limited IPO Allotment Status

Click Here To Check IPO Allotment Status Akums Drugs and Pharmaceuticals Limited IPO

Click Here To Get ASBA Forms Akums Drugs and Pharmaceuticals Limited IPO

Company Financials:

Particular31 March 202431 March 202331 March 2022
Total Assets3516.373266.533069.05
Total Revenue4212.213700.933694.52
Profit After Tax0.7997.82-250.87
For the year/period ended (₹ in million)

Company Promoters:

Sanjeev Jain, Sandeep Jain, and Akums Master Trust are the company’s promoters.

Objects of this Issue:

  • Repayment/ prepayment of indebtedness of the company and its Subsidiaries;
  • Funding incremental working capital requirements of the company;
  • Pursuing inorganic growth initiatives through acquisitions; and
  • General corporate purposes.

Registrar & Company Details

Company Contact InformationIPO Registrar
Akums Drugs and Pharmaceuticals Limited

304, Mohan Place,
LSC Saraswati Vihar,
Delhi – 110 034
Phone: +91 11 6904 1000
Email: cs@akums.net
Website: http://www.akums.in
Link Intime India Private Ltd




Phone: +91-22-4918 6270
Email: akumsdrugs.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html

Related posts

Leave a Comment